Brokerage firm Prabhudas Lilladher has updated its outlook on Mold-Tek Packaging, raising the target price to ₹730. The revision reflects optimism around sustained volume growth and improved profit margins per kilogram. Investors are closely tracking the company's capacity expansion plans at its Cheyyar and Panipat facilities as a key driver for future performance.
Detailed Coverage
Prabhudas Lilladher has adjusted its earnings outlook for Mold-Tek Packaging, increasing its earnings per share estimates for the coming years. This update follows the company’s recent performance, which showed stronger-than-expected growth in product realization. The brokerage now expects the company to see a steady compound annual growth rate in both sales and earnings through FY28.
Profit Margins and Volume Outlook
A central focus for investors is the improvement in profitability per unit. The company has guided for an EBITDA per kilogram of ₹43 or higher for FY27, a slight upward revision from its previous estimates. This shift is primarily driven by a better mix of products sold, which allows for higher margins. Additionally, Mold-Tek Packaging has maintained its commitment to achieving 10-12% volume growth in FY27. This growth is supported by steady demand from key sectors, including fast-moving consumer goods (FMCG), paints, and the pharmaceutical industry.
Impact of Capacity Expansion
The company is currently scaling up its operations to meet rising market demand. Investors may monitor the progress of new capacity additions at the Cheyyar and Panipat plants. As these facilities become fully operational, the company expects its overall capacity utilization to climb, with projections suggesting a move above 70% in FY27. Higher utilization is generally positive for profitability as it allows the company to spread fixed costs across a larger volume of output.
Sector Context and Monitorables
While the company continues to see recovery in its lubricants segment on a quarter-on-quarter basis, its success remains tied to the broader demand environment in its core customer industries. Successful addition of new clients has historically helped the company mitigate risks associated with sector-specific slowdowns.
Looking ahead, the main factors for investors to track include the actual execution speed of the expansion projects and whether the company can sustain its improved EBITDA per kilogram levels amidst competitive pricing. The final financial impact will depend on the company's ability to maintain these margins while managing costs effectively as it scales its operations in the pharmaceutical and FMCG segments.